High-Density Lipoproteins in the Prevention of Cardiovascular Disease: Changing the Paradigm
出版年份 2014 全文链接
标题
High-Density Lipoproteins in the Prevention of Cardiovascular Disease: Changing the Paradigm
作者
关键词
-
出版物
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 96, Issue 1, Pages 48-56
出版商
Springer Nature
发表日期
2014-04-08
DOI
10.1038/clpt.2014.79
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Residual macrovascular risk in 2013: what have we learned?
- (2014) Jean-Charles Fruchart et al. Cardiovascular Diabetology
- Evaluation of Lipids, Drug Concentration, and Safety Parameters Following Cessation of Treatment With the Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib in Patients With or at High Risk for Coronary Heart Disease
- (2013) Antonio M. Gotto et al. AMERICAN JOURNAL OF CARDIOLOGY
- Levels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients
- (2013) S. Matthijs Boekholdt et al. CIRCULATION
- Heart Disease and Stroke Statistics—2014 Update
- (2013) Alan S. Go et al. CIRCULATION
- Genetics of HDL-C: A Causal Link to Atherosclerosis?
- (2013) Julian C. van Capelleveen et al. Current Atherosclerosis Reports
- Recent advances in niacin and lipid metabolism
- (2013) Vaijinath S. Kamanna et al. CURRENT OPINION IN LIPIDOLOGY
- HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
- (2013) et al. EUROPEAN HEART JOURNAL
- Niacin, an old drug with a new twist
- (2013) Wen-Liang Song et al. JOURNAL OF LIPID RESEARCH
- Cardioprotective functions of HDLs
- (2013) Kerry-Anne Rye et al. JOURNAL OF LIPID RESEARCH
- The Addition of Niacin to Statin Therapy Improves High-Density Lipoprotein Cholesterol Levels But Not Metrics of Functionality
- (2013) Amit V. Khera et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Common variants associated with plasma triglycerides and risk for coronary artery disease
- (2013) Ron Do et al. NATURE GENETICS
- Discovery and refinement of loci associated with lipid levels
- (2013) Cristen J Willer et al. NATURE GENETICS
- High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3
- (2013) Dominic De Nardo et al. NATURE IMMUNOLOGY
- Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial
- (2012) Thomas F. Lüscher et al. EUROPEAN HEART JOURNAL
- Relationship between atorvastatin dose and the harm caused by torcetrapib
- (2012) Philip J. Barter et al. JOURNAL OF LIPID RESEARCH
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
- (2012) Benjamin F Voight et al. LANCET
- Is it time to revise the HDL cholesterol hypothesis?
- (2012) Daniel J Rader et al. NATURE MEDICINE
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Niacin Lipid Efficacy Is Independent of Both the Niacin Receptor GPR109A and Free Fatty Acid Suppression
- (2012) B. Lauring et al. Science Translational Medicine
- Dense Genotyping of Candidate Gene Loci Identifies Variants Associated With High-Density Lipoprotein Cholesterol
- (2011) Andrew C. Edmondson et al. Circulation-Cardiovascular Genetics
- Torcetrapib impairs endothelial function in hypertension
- (2011) Branko Simic et al. EUROPEAN HEART JOURNAL
- Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol
- (2011) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure
- (2011) Guoqing Cao et al. JOURNAL OF LIPID RESEARCH
- Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
- (2011) Zahi A Fayad et al. LANCET
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
- (2011) Amit V. Khera et al. NEW ENGLAND JOURNAL OF MEDICINE
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From Macrophages
- (2010) Margarita de la Llera-Moya et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cholesterol Efflux Potential and Antiinflammatory Properties of High-Density Lipoprotein After Treatment With Niacin or Anacetrapib
- (2010) Laurent Yvan-Charvet et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Future Therapeutic Directions in Reverse Cholesterol Transport
- (2010) Amit V. Khera et al. Current Atherosclerosis Reports
- Lipoprotein(a) as a cardiovascular risk factor: current status
- (2010) Børge G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- Biochemical characterization of cholesteryl ester transfer protein inhibitors
- (2010) Mollie Ranalletta et al. JOURNAL OF LIPID RESEARCH
- Pioglitazone increases apolipoprotein A-I production by directly enhancing PPRE-dependent transcription in HepG2 cells
- (2010) Lin-Hua Zhang et al. JOURNAL OF LIPID RESEARCH
- Biological, clinical and population relevance of 95 loci for blood lipids
- (2010) Tanya M. Teslovich et al. NATURE
- Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease
- (2010) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- High density lipoprotein: it's not just about lipid transport anymore
- (2010) Scott M. Gordon et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Design of the DEFINE trial: Determining the EFficacy and Tolerability of CETP INhibition with AnacEtrapib
- (2009) Christopher P. Cannon et al. AMERICAN HEART JOURNAL
- Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
- (2009) M. J. Chapman et al. EUROPEAN HEART JOURNAL
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Reconstituted High-Density Lipoprotein Increases Plasma High-Density Lipoprotein Anti-Inflammatory Properties and Cholesterol Efflux Capacity in Patients With Type 2 Diabetes
- (2009) Sanjay Patel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Extended-Release Niacin or Ezetimibe and Carotid Intima–Media Thickness
- (2009) Allen J. Taylor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients
- (2008) Daniel Bloomfield et al. AMERICAN HEART JOURNAL
- Niacin Increases HDL by Reducing Hepatic Expression and Plasma Levels of Cholesteryl Ester Transfer Protein in APOE*3Leiden.CETP Mice
- (2008) José W.A. van der Hoorn et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone
- (2008) M J Forrest et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cholesteryl Ester Transfer Protein Inhibition, High-Density Lipoprotein Raising, and Progression of Coronary Atherosclerosis
- (2008) Stephen J. Nicholls et al. CIRCULATION
- Association of Cholesteryl Ester Transfer Protein Genotypes With CETP Mass and Activity, Lipid Levels, and Coronary Risk
- (2008) Alexander Thompson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Niacin inhibits surface expression of ATP synthase β chain in HepG2 cells: implications for raising HDL
- (2008) Lin-Hua Zhang et al. JOURNAL OF LIPID RESEARCH
- The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis
- (2008) Daniel J. Rader et al. JOURNAL OF LIPID RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search